SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003163
Filing Date
2022-11-10
Accepted
2022-11-10 17:00:55
Documents
50
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q snpx-20220930x10q.htm   iXBRL 10-Q 1401917
2 EX-31._1 snpx-20220930xex31d1.htm EX-31._1 13845
3 EX-31._2 snpx-20220930xex31d2.htm EX-31._2 14529
4 EX-32._1 snpx-20220930xex32d1.htm EX-32._1 10395
5 EX-32._2 snpx-20220930xex32d2.htm EX-32._2 10200
  Complete submission text file 0001410578-22-003163.txt   5268207

Data Files

Seq Description Document Type Size
6 EX-101.SCH snpx-20220930.xsd EX-101.SCH 45402
7 EX-101.CAL snpx-20220930_cal.xml EX-101.CAL 20869
8 EX-101.DEF snpx-20220930_def.xml EX-101.DEF 175882
9 EX-101.LAB snpx-20220930_lab.xml EX-101.LAB 315203
10 EX-101.PRE snpx-20220930_pre.xml EX-101.PRE 272872
44 EXTRACTED XBRL INSTANCE DOCUMENT snpx-20220930x10q_htm.xml XML 679903
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

IRS No.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40458 | Film No.: 221378291
SIC: 2834 Pharmaceutical Preparations